David K. Crossen, 45 years old, resigned as president and chief executive officer of this developer of anti-inflammatory drugs to pursue other interests, the company said.
In a news release, Cortech's chairman, Bert Fingerhut, thanked Mr. Crossen and praised his six-year tenure.
The company named Paul J. Jerde, 46, vice chairman and acting CEO.
Mr. Jerde has been a Cortech director since 1985.
